ACAD
ACADIA PHARMACEUTICALS INC
Company overview
- Market capitalization
- $3.54B
- Employees
- 796
- Latest publication
- 2026-09-29
About ACADIA PHARMACEUTICALS INC
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America. The company offers NUPLAZID (pimavanserin), a selective serotonin inverse agonist/antagonist for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 to treat the symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function. It also develops remlifanserin, which is in phase 2 clinical trial for the treatment of alzheimer's disease psychosis and lewy body dementia psychosis; ACP-211, which is in phase 2 clinical trial to treat major depressive disorder; ACP-711, which is in phase I clinical trial for the treatment of essential tremor; and ACP-271, a GPR88 agonist for the treatment of tardive dyskinesia and huntington's disease and is in phase I trial. In addition, the company develops ACP-2591, a cGP analogue which is in Phase 1 clinical trial to treat rett syndrome and fragile X syndrome; and STOKE Antisense Oligonucleotide Program, which is in discovery program for SYNGAP1 syndrome. It has a license agreement with Neuren Pharmaceuticals Limited to trofinetide for Rett syndrome and other indications; and a license and collaboration agreement with Stoke Therapeutics, Inc. to discover, develop, and commercialize novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The company was formerly known as Receptor Technologies, Inc. and changed its name ACADIA Pharmaceuticals Inc. in 1997. ACADIA Pharmaceuticals Inc. was incorporated in 1993 and is headquartered in San Diego, California.
Financial statements
Income Quarterly
| Metric | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 283,989,000USD | 278,633,000USD | 264,566,000USD | 244,317,000USD | 259,602,000USD | 250,401,000USD | 241,963,000USD | 205,831,000USD |
| Cost Of Revenue | 26,225,000USD | 21,647,000USD | 20,734,000USD | 20,392,000USD | 21,803,000USD | 18,857,000USD | 18,230,000USD | 22,951,000USD |
| Gross Profit | 257,764,000USD | 256,986,000USD | 243,832,000USD | 223,925,000USD | 237,799,000USD | 231,544,000USD | 223,733,000USD | 182,880,000USD |
| Research Development | 84,757,000USD | 87,829,000USD | 77,951,000USD | 78,265,000USD | 100,731,000USD | 66,606,000USD | 76,233,000USD | 59,679,000USD |
| Selling General Administrative | 155,616,000USD | 133,401,000USD | 133,507,000USD | 126,370,000USD | 130,080,000USD | 133,294,000USD | 117,063,000USD | 107,991,000USD |
| Total Operating Expenses | 240,373,000USD | 221,230,000USD | 211,458,000USD | 204,635,000USD | 84,296,000USD | 199,900,000USD | 193,296,000USD | 167,670,000USD |
| Operating Income | 17,391,000USD | 35,756,000USD | 32,374,000USD | 19,290,000USD | 153,503,000USD | 31,644,000USD | 30,437,000USD | 15,210,000USD |
| Interest Income | 8,332,000USD | 8,246,000USD | 7,243,000USD | 7,901,000USD | 7,007,000USD | 6,586,000USD | 6,359,000USD | 5,506,000USD |
| Net Interest Income | 8,332,000USD | 8,246,000USD | 7,243,000USD | 7,901,000USD | 7,007,000USD | 6,586,000USD | 6,359,000USD | 5,506,000USD |
| Income Before Tax | 26,319,000USD | 44,595,000USD | 40,211,000USD | 27,779,000USD | 161,085,000USD | 38,806,000USD | 37,182,000USD | 21,002,000USD |
| Income Tax Expense | -247,249,000USD | -27,184,000USD | 13,545,000USD | 8,792,000USD | 17,343,000USD | 6,041,000USD | 3,793,000USD | 4,447,000USD |
| Tax Provision | -247,249,000USD | -27,184,000USD | 13,545,000USD | 8,792,000USD | 17,343,000USD | 6,041,000USD | 3,793,000USD | 4,447,000USD |
| Net Income | 273,568,000USD | 71,779,000USD | 26,666,000USD | 18,987,000USD | 143,742,000USD | 32,765,000USD | 33,389,000USD | 16,555,000USD |
| Net Income From Continuing Ops | 273,568,000USD | 71,779,000USD | 26,666,000USD | 18,987,000USD | 143,742,000USD | 32,765,000USD | 33,389,000USD | 16,555,000USD |
| Ebit | 26,319,000USD | 44,595,000USD | 40,211,000USD | 27,779,000USD | 6,988,000USD | 38,806,000USD | 37,182,000USD | 21,002,000USD |
| Ebitda | 29,243,000USD | 47,545,000USD | 43,146,000USD | 30,730,000USD | 12,202,000USD | 41,376,000USD | 39,753,000USD | 26,530,000USD |
| Depreciation And Amortization | 2,924,000USD | 2,950,000USD | 2,935,000USD | 2,951,000USD | 5,214,000USD | 2,570,000USD | 2,571,000USD | 5,528,000USD |
| Reconciled Depreciation | 2,924,000USD | 2,950,000USD | 2,935,000USD | 2,951,000USD | 5,214,000USD | 2,570,000USD | 2,571,000USD | 5,528,000USD |
| Total Other Income Expense Net | 8,928,000USD | 8,839,000USD | 7,837,000USD | 8,489,000USD | 7,582,000USD | 7,162,000USD | 6,745,000USD | 5,792,000USD |
| Unclassified Operating Expenses | — | — | — | — | -146,515,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20152015-12-31 · USD | FY 20142014-12-31 · USD | FY 20132013-12-31 · USD | FY 20122012-12-31 · USD | FY 20112011-12-31 · USD | FY 20102010-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,071,505,000USD | 957,797,000USD | 61,000USD | 120,000USD | 1,145,000USD | 4,907,000USD | 2,067,000USD | 42,135,000USD |
| Cost Of Revenue | 88,998,000USD | 81,841,000USD | 2,500,000USD | 93,144,000USD | 26,722,000USD | 25,684,000USD | 23,534,000USD | 26,434,000USD |
| Gross Profit | 982,507,000USD | 875,956,000USD | 61,000USD | 120,000USD | -25,577,000USD | 4,907,000USD | 2,067,000USD | 42,135,000USD |
| Research Development | 328,802,000USD | 303,249,000USD | 73,869,000USD | 60,602,000USD | 26,722,000USD | 18,794,000USD | 17,309,000USD | 20,579,000USD |
| Selling General Administrative | 548,894,000USD | 488,428,000USD | 90,804,000USD | 32,748,000USD | 12,720,000USD | 6,999,000USD | 7,610,000USD | 6,462,000USD |
| Total Operating Expenses | 877,696,000USD | 645,162,000USD | 164,673,000USD | 93,350,000USD | 39,442,000USD | 25,793,000USD | 24,919,000USD | 27,041,000USD |
| Operating Income | 104,811,000USD | 230,794,000USD | -164,612,000USD | -93,230,000USD | -38,297,000USD | -20,886,000USD | -22,852,000USD | 15,094,000USD |
| Interest Income | 31,722,000USD | 25,458,000USD | 499,000USD | — | — | — | — | — |
| Net Interest Income | 31,722,000USD | 25,458,000USD | — | — | — | — | — | — |
| Income Before Tax | 138,904,000USD | 258,075,000USD | -164,113,000USD | -92,475,000USD | -37,948,000USD | -20,849,000USD | -22,765,000USD | 15,139,000USD |
| Income Tax Expense | -252,096,000USD | 31,624,000USD | 330,000USD | -206,000USD | 0USD | -109,000USD | 0USD | — |
| Tax Provision | -252,096,000USD | 31,624,000USD | 330,000USD | — | — | — | — | — |
| Net Income | 391,000,000USD | 226,451,000USD | -164,443,000USD | -92,475,000USD | -37,948,000USD | -20,849,000USD | -22,765,000USD | 15,139,000USD |
| Net Income From Continuing Ops | 391,000,000USD | 226,451,000USD | -164,443,000USD | -92,475,000USD | -37,948,000USD | -20,849,000USD | -22,765,000USD | — |
| Ebit | 138,904,000USD | 84,279,000USD | -164,612,000USD | -93,230,000USD | -38,297,000USD | -20,886,000USD | -22,765,000USD | 15,094,000USD |
| Ebitda | 150,664,000USD | 100,162,000USD | -163,965,000USD | -93,024,000USD | -38,218,000USD | -20,777,000USD | -22,480,000USD | 15,701,000USD |
| Depreciation And Amortization | 11,760,000USD | 15,883,000USD | 647,000USD | 206,000USD | 79,000USD | 109,000USD | 285,000USD | 607,000USD |
| Reconciled Depreciation | 11,760,000USD | 15,883,000USD | — | — | — | — | — | — |
| Total Other Income Expense Net | 34,093,000USD | 27,281,000USD | 499,000USD | 755,000USD | 349,000USD | 37,000USD | 87,000USD | 45,000USD |
| Unclassified Operating Expenses | — | -146,515,000USD | — | — | — | — | — | — |
| Interest Expense | — | — | 0USD | 0USD | 0USD | 0USD | 0USD | 37,000USD |
| Net Income Applicable To Common Shares | — | — | -164,443,000USD | -92,475,000USD | -37,948,000USD | -20,849,000USD | -22,765,000USD | 15,139,000USD |
| Non Operating Income Net Other | — | — | — | — | — | 37,000USD | 87,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,605,230,000USD | 1,564,195,000USD | 1,330,771,000USD | 1,225,555,000USD | 1,132,364,000USD | 1,187,756,000USD | 976,868,000USD | 914,099,000USD |
| Intangible Assets | 106,171,000USD | 108,893,000USD | 111,615,000USD | 114,338,000USD | 117,060,000USD | 119,782,000USD | 105,515,000USD | 107,859,000USD |
| Other Current Assets | 64,599,999USD | 59,526,000USD | 60,868,000USD | 52,747,000USD | 52,703,000USD | 55,681,000USD | 63,704,000USD | 46,056,000USD |
| Total Liab | 357,164,000USD | 336,805,000USD | 413,499,000USD | 403,173,000USD | 367,127,000USD | 454,963,000USD | 399,688,000USD | 397,399,000USD |
| Total Stockholder Equity | 1,248,066,000USD | 1,227,390,000USD | 917,272,000USD | 822,382,000USD | 765,237,000USD | 732,793,000USD | 577,180,000USD | 516,700,000USD |
| Other Current Liab | 281,487,000USD | 254,578,000USD | 323,054,000USD | 298,234,000USD | 264,015,000USD | 356,704,000USD | 315,915,000USD | 299,043,000USD |
| Common Stock | 16,000USD | 16,000USD | 16,000USD | 16,000USD | 16,000USD | 16,000USD | 16,000USD | 16,000USD |
| Capital Stock | 16,000USD | 16,000USD | 16,000USD | 16,000USD | 16,000USD | 16,000USD | 16,000USD | 16,000USD |
| Retained Earnings | -1,809,749,000USD | -1,813,386,000USD | -2,086,954,000USD | -2,158,733,000USD | -2,185,399,000USD | -2,204,386,000USD | -2,348,128,000USD | -2,380,893,000USD |
| Other Assets | 1USD | — | — | — | — | — | — | — |
| Cash | 282,212,000USD | 177,695,000USD | 257,995,999USD | 253,637,000USD | 217,696,000USD | 319,589,000USD | 155,149,000USD | 177,134,000USD |
| Cash And Short Term Investments | 851,458,000USD | 819,686,000USD | 847,019,000USD | 761,996,000USD | 681,577,000USD | 755,993,000USD | 565,330,000USD | 500,942,000USD |
| Total Current Assets | 1,096,016,000USD | 1,062,113,000USD | 1,076,422,000USD | 960,553,000USD | 870,942,000USD | 938,318,000USD | 788,284,000USD | 728,916,000USD |
| Total Current Liabilities | 305,524,000USD | 277,114,000USD | 356,584,000USD | 330,024,000USD | 302,530,000USD | 394,870,000USD | 343,945,000USD | 337,851,000USD |
| Net Debt | -231,418,000USD | -125,508,000USD | -203,186,999USD | -197,343,000USD | -161,690,000USD | -267,594,000USD | -105,779,000USD | -119,478,000USD |
| Short Term Debt | 11,791,000USD | 11,633,000USD | 11,783,000USD | 11,693,000USD | 11,372,000USD | 9,958,000USD | 8,949,000USD | 10,470,000USD |
| Short Long Term Debt Total | 50,794,000USD | 52,187,000USD | 54,809,000USD | 56,294,000USD | 56,006,000USD | 51,995,000USD | 49,370,000USD | 57,656,000USD |
| Short Term Investments | 569,246,000USD | 641,991,000USD | 589,023,000USD | 508,359,000USD | 463,881,000USD | 436,404,000USD | 410,181,000USD | 323,808,000USD |
| Net Receivables | 148,384,000USD | 148,231,000USD | 139,438,000USD | 119,686,000USD | 113,714,000USD | 104,695,000USD | 98,209,000USD | 110,393,000USD |
| Inventory | 31,574,000USD | 34,670,000USD | 29,097,000USD | 26,124,000USD | 22,948,000USD | 21,949,000USD | 61,041,000USD | 71,525,000USD |
| Accounts Payable | 12,246,000USD | 10,903,000USD | 21,747,000USD | 20,097,000USD | 18,095,000USD | 16,192,000USD | 19,081,000USD | 19,882,000USD |
| Property Plant Equipment Net | 60,926,000USD | 54,865,000USD | 53,381,000USD | 54,538,000USD | 54,112,000USD | 50,786,000USD | 48,241,000USD | 56,534,000USD |
| Property Plant Equipment Gross | 60,926,000USD | 64,349,000USD | 53,381,000USD | 54,538,000USD | 54,112,000USD | 61,003,000USD | 48,241,000USD | 56,534,000USD |
| Accumulated Other Comprehensive Income | -563,000USD | 1,445,000USD | 989,000USD | 406,000USD | 437,000USD | 292,000USD | 858,000USD | -339,000USD |
| Common Stock Shares Outstanding | 172,706,000shares | 171,359,000shares | 170,650,000shares | 168,681,000shares | 167,668,000shares | 166,362,000shares | 166,178,000shares | 166,174,000shares |
| Non Current Assets Total | 509,213,999USD | 502,081,999USD | 254,348,999USD | 265,002,000USD | 261,422,000USD | 249,438,000USD | 188,584,000USD | 185,183,000USD |
| Non Current Liabilities Total | 51,640,000USD | 59,691,000USD | 56,915,000USD | 73,149,000USD | 64,597,000USD | 60,093,000USD | 55,743,000USD | 59,548,000USD |
| Non Current Liabilities Other | 12,637,000USD | 19,137,000USD | 13,889,000USD | 28,548,000USD | 19,963,000USD | 18,056,000USD | 15,322,000USD | 12,362,000USD |
| Non Currrent Assets Other | 84,646,999USD | 80,599,999USD | 79,881,999USD | 86,655,000USD | 81,480,000USD | 70,100,000USD | 26,058,000USD | 15,020,000USD |
| Net Working Capital | 790,492,000USD | 784,999,000USD | 719,838,000USD | 630,529,000USD | 568,412,000USD | 543,448,000USD | 444,339,000USD | 391,065,000USD |
| Unclassified Non Current Assets | 257,469,999USD | 257,724,000USD | 9,471,000USD | 9,471,000USD | 8,770,000USD | 8,770,000USD | 8,770,000USD | 5,770,000USD |
| Unclassified Non Current Liabilities | 39,003,000USD | 40,554,000USD | 43,026,000USD | 44,601,000USD | 44,634,000USD | 42,037,000USD | 40,421,000USD | 47,186,000USD |
| Unclassified Equity | 3,058,346,000USD | 3,039,299,000USD | 3,003,205,000USD | 2,980,677,000USD | 2,950,167,000USD | 2,936,855,000USD | 2,924,418,000USD | 2,897,900,000USD |
| Unclassified Current Liabilities | — | — | — | — | 9,048,000USD | 12,016,000USD | — | — |
| Current Deferred Revenue | — | — | — | — | — | — | — | 8,456,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,564,195,000USD | 1,187,756,000USD | 748,956,000USD | 587,812,000USD | 700,122,000USD | 782,616,000USD | 783,183,000USD | 540,202,000USD |
| Intangible Assets | 108,893,000USD | 119,782,000USD | 65,489,999USD | — | — | 1,108,000USD | 2,585,000USD | 4,062,000USD |
| Other Current Assets | 59,526,000USD | 55,681,000USD | 39,091,000USD | 21,398,000USD | 23,892,000USD | 25,694,000USD | 18,606,000USD | 20,727,000USD |
| Total Liab | 336,805,000USD | 454,963,000USD | 317,201,000USD | 187,399,000USD | 159,228,000USD | 155,607,000USD | 84,048,000USD | 61,123,000USD |
| Total Stockholder Equity | 1,227,390,000USD | 732,793,000USD | 431,755,000USD | 400,413,000USD | 540,894,000USD | 627,009,000USD | 699,135,000USD | 479,079,000USD |
| Other Current Liab | 254,578,000USD | 356,704,000USD | 225,742,000USD | 103,202,000USD | 80,888,000USD | 92,387,000USD | 64,170,000USD | 56,398,000USD |
| Common Stock | 16,000USD | 16,000USD | 16,000USD | 16,000USD | 16,000USD | 16,000USD | 15,000USD | 14,000USD |
| Capital Stock | 16,000USD | 16,000USD | 16,000USD | 16,000USD | 16,000USD | 16,000USD | 15,000USD | 14,000USD |
| Retained Earnings | -1,813,386,000USD | -2,204,386,000USD | -2,430,837,000USD | -2,369,551,000USD | -2,153,576,000USD | -1,985,706,000USD | -1,704,122,000USD | -1,468,863,000USD |
| Cash | 177,695,000USD | 319,589,000USD | 188,657,000USD | 114,846,000USD | 147,435,000USD | 326,028,000USD | 189,680,000USD | 134,758,000USD |
| Cash And Short Term Investments | 819,686,000USD | 755,993,000USD | 438,865,000USD | 416,823,000USD | 520,706,000USD | 631,958,000USD | 697,429,000USD | 473,520,000USD |
| Total Current Assets | 1,062,113,000USD | 938,318,000USD | 616,125,000USD | 507,937,000USD | 617,823,000USD | 717,616,000USD | 760,250,000USD | 526,106,000USD |
| Total Current Liabilities | 277,114,000USD | 394,870,000USD | 254,254,000USD | 125,630,000USD | 96,068,000USD | 105,967,000USD | 74,826,000USD | 59,565,000USD |
| Net Debt | -125,508,000USD | -267,594,000USD | -131,452,000USD | -52,846,000USD | -83,005,000USD | -276,481,000USD | -179,885,000USD | -134,758,000USD |
| Short Term Debt | 11,633,000USD | 9,958,000USD | 9,405,000USD | 9,305,000USD | 8,304,000USD | 5,087,000USD | 3,434,000USD | — |
| Short Long Term Debt Total | 52,187,000USD | 51,995,000USD | 57,205,000USD | 62,000,000USD | 64,430,000USD | 49,547,000USD | 9,795,000USD | — |
| Short Term Investments | 641,991,000USD | 436,404,000USD | 250,208,000USD | 301,977,000USD | 373,271,000USD | 305,930,000USD | 507,749,000USD | 338,762,000USD |
| Net Receivables | 148,231,000USD | 104,695,000USD | 102,350,000USD | 63,080,000USD | 65,344,000USD | 50,282,000USD | 37,874,000USD | 27,789,000USD |
| Inventory | 34,670,000USD | 21,949,000USD | 35,819,000USD | 6,636,000USD | 7,881,000USD | 9,682,000USD | 6,341,000USD | 4,070,000USD |
| Accounts Payable | 10,903,000USD | 16,192,000USD | 17,543,000USD | 12,746,000USD | 6,876,000USD | 8,493,000USD | 7,222,000USD | 3,167,000USD |
| Property Plant Equipment Net | 54,865,000USD | 50,786,000USD | 56,467,000USD | 61,594,000USD | 66,315,000USD | 56,444,000USD | 12,704,000USD | 3,309,000USD |
| Property Plant Equipment Gross | 64,349,000USD | 61,003,000USD | 66,023,000USD | 61,594,000USD | 66,315,000USD | 56,444,000USD | 12,704,000USD | 3,309,000USD |
| Accumulated Other Comprehensive Income | 1,445,000USD | 292,000USD | 24,000USD | -975,000USD | -192,000USD | 36,000USD | 297,000USD | -372,000USD |
| Common Stock Shares Outstanding | 171,359,000shares | 166,362,000shares | 163,819,000shares | 161,683,000shares | 160,493,000shares | 157,331,000shares | 147,199,000shares | 126,583,000shares |
| Non Current Assets Total | 502,081,999USD | 249,438,000USD | 132,831,000USD | 79,875,000USD | 82,299,000USD | 65,000,000USD | 22,932,999USD | 14,096,000USD |
| Non Current Liabilities Total | 59,691,000USD | 60,093,000USD | 62,947,000USD | 61,769,000USD | 63,160,000USD | 49,640,000USD | 9,222,000USD | 1,558,000USD |
| Non Current Liabilities Other | 19,137,000USD | 18,056,000USD | 15,147,000USD | 9,074,000USD | 7,034,000USD | 49,640,000USD | 9,222,000USD | 1,558,000USD |
| Non Currrent Assets Other | 80,599,999USD | 78,870,000USD | 5,104,000USD | 5,311,000USD | 12,384,000USD | 378,000USD | 556,999USD | 6,725,000USD |
| Net Working Capital | 784,999,000USD | 543,448,000USD | 361,871,000USD | 382,307,000USD | 521,755,000USD | 611,649,000USD | 685,424,000USD | 466,541,000USD |
| Unclassified Non Current Assets | 257,724,000USD | — | 5,770,000USD | 1,889,000USD | -12,384,000USD | -47,661,000USD | — | -6,725,000USD |
| Unclassified Non Current Liabilities | 40,554,000USD | 42,037,000USD | 47,800,000USD | 43,621,000USD | 49,092,000USD | -5,180,000USD | -2,861,000USD | -1,558,000USD |
| Unclassified Equity | 3,039,299,000USD | 2,936,855,000USD | 2,862,536,000USD | 2,770,907,000USD | 2,694,630,000USD | 2,612,647,000USD | 2,402,930,000USD | 1,948,286,000USD |
| Unclassified Current Liabilities | — | 12,016,000USD | — | — | — | — | — | — |
| Good Will | — | — | 1USD | — | — | — | — | — |
| Current Deferred Revenue | — | — | 1,564,000USD | — | — | — | — | — |
| Other Liab | — | — | — | 9,074,000USD | 7,034,000USD | 5,180,000USD | 2,861,000USD | 1,558,000USD |
| Other Assets | — | — | — | 11,081,000USD | 15,984,000USD | 54,731,000USD | 5,344,000USD | 5,425,000USD |
| Net Tangible Assets | — | — | — | 400,413,000USD | 540,894,000USD | 625,901,000USD | 696,550,000USD | 475,017,000USD |
| Long Term Investments | — | — | — | — | — | — | 2,300,000USD | 1,300,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 3,637,000USD | 273,568,000USD | 71,779,000USD | 26,666,000USD | 18,987,000USD | 143,742,000USD | 32,765,000USD | 33,389,000USD |
| Depreciation | 2,993,000USD | 2,924,000USD | 2,950,000USD | -1,159,000USD | 2,951,000USD | 5,214,000USD | 2,570,000USD | 2,571,000USD |
| Stock Based Compensation | 14,698,000USD | 13,235,000USD | 13,180,000USD | 14,340,000USD | 11,380,000USD | 10,450,000USD | 26,164,000USD | 15,685,000USD |
| Other Non Cash Items | -453,000USD | 12,565,000USD | -1,102,000USD | 2,558,000USD | -2,116,000USD | -149,332,000USD | -2,747,000USD | -1,954,000USD |
| Change To Account Receivables | -153,000USD | -8,799,000USD | -19,746,000USD | -5,972,000USD | -9,019,000USD | 5,668,000USD | 30,000USD | -10,314,000USD |
| Change To Inventory | 78,000USD | -4,892,000USD | 1,248,000USD | -4,100,000USD | -10,453,000USD | -4,424,000USD | -1,331,000USD | -27,147,000USD |
| Change In Working Capital | 13,200,000USD | -87,909,000USD | -12,519,000USD | 21,551,000USD | -10,879,000USD | 30,307,000USD | 4,494,000USD | -24,678,000USD |
| Total Cash From Operating Activities | 33,981,000USD | -48,731,000USD | 74,288,000USD | 63,956,000USD | 20,323,000USD | 40,381,000USD | 63,246,000USD | 25,013,000USD |
| Capital Expenditures | -5,212,000USD | -4,005,000USD | -388,000USD | 98,541,000USD | -98,838,000USD | -453,000USD | -70,000USD | 0USD |
| Free Cash Flow | 28,769,000USD | -52,736,000USD | 73,900,000USD | 162,497,000USD | -78,515,000USD | 39,928,000USD | 63,176,000USD | 25,013,000USD |
| Investments | 71,493,000USD | -51,864,000USD | -79,352,000USD | -43,294,000USD | -124,049,000USD | 122,150,000USD | -82,457,000USD | -56,192,000USD |
| Total Cashflows From Investing Activities | 66,281,000USD | -55,869,000USD | -79,352,000USD | -43,294,000USD | -124,049,000USD | 122,150,000USD | -82,457,000USD | -56,192,000USD |
| Total Cash From Financing Activities | 4,231,000USD | 22,666,000USD | 9,423,000USD | 15,956,000USD | 1,838,000USD | 1,969,000USD | 268,000USD | 3,565,000USD |
| Issuance Of Capital Stock | 4,231,000USD | 22,666,000USD | 9,423,000USD | 15,956,000USD | 1,838,000USD | 1,969,000USD | 268,000USD | 3,565,000USD |
| Change In Cash | 104,517,000USD | -80,300,999USD | 4,359,000USD | 36,642,000USD | -101,893,000USD | 164,440,000USD | -18,985,000USD | -27,611,000USD |
| Begin Period Cash Flow | 177,695,000USD | 257,995,999USD | 263,108,000USD | 226,466,000USD | 328,359,000USD | 163,919,000USD | 182,904,000USD | 210,515,000USD |
| End Period Cash Flow | 282,212,000USD | 177,695,000USD | 267,467,000USD | 263,108,000USD | 226,466,000USD | 328,359,000USD | 163,919,000USD | 182,904,000USD |
| Unclassified Operating Cash Flow | — | -263,114,000USD | — | — | — | — | — | — |
| Other Cashflows From Financing Activities | — | — | 9,423,000USD | — | — | — | -82,457,000USD | -56,192,000USD |
| Unclassified Financing Cash Flow | — | — | -9,423,000USD | — | — | — | 86,217,000USD | 56,265,000USD |
| Other Cashflows From Investing Activities | — | — | — | -98,838,000USD | — | 146,515,000USD | — | -56,192,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | 98,838,000USD | -146,062,000USD | — | 56,192,000USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | -3,492,000USD | 3,492,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 391,000,000USD | 226,451,000USD | -61,286,000USD | -215,975,000USD | -167,870,000USD | -281,584,000USD | -235,259,000USD | -245,192,000USD |
| Depreciation | 11,760,000USD | 15,883,000USD | 5,552,000USD | 2,026,000USD | 3,344,000USD | 2,932,000USD | 2,766,000USD | 3,005,000USD |
| Stock Based Compensation | 52,135,000USD | 67,049,000USD | 66,421,000USD | 68,201,000USD | 63,615,000USD | 84,422,000USD | 82,265,000USD | 81,564,000USD |
| Other Non Cash Items | 46,711,000USD | -155,819,000USD | -12,118,000USD | -6,278,000USD | 75,000USD | 44,280,000USD | -4,607,000USD | 1,350,000USD |
| Change To Account Receivables | -43,536,000USD | -2,345,000USD | -39,270,000USD | 2,264,000USD | -16,119,000USD | -12,466,000USD | -9,691,000USD | -8,747,000USD |
| Change To Inventory | -18,197,000USD | -49,550,000USD | -28,808,000USD | 2,415,000USD | -4,210,000USD | -3,320,000USD | -1,737,000USD | 1,926,000USD |
| Change In Working Capital | -89,756,000USD | 4,155,000USD | 18,133,000USD | 37,991,000USD | -24,824,000USD | 11,036,000USD | 3,705,000USD | -8,197,000USD |
| Total Cash From Operating Activities | 109,836,000USD | 157,719,000USD | 16,702,000USD | -114,035,000USD | -125,660,000USD | -136,166,000USD | -151,130,000USD | -167,470,000USD |
| Capital Expenditures | -4,690,000USD | -523,000USD | -40,050,000USD | 0USD | -1,122,000USD | -7,587,000USD | -1,129,000USD | -2,148,000USD |
| Free Cash Flow | 105,146,000USD | 157,196,000USD | -23,348,000USD | -114,035,000USD | -126,782,000USD | -143,753,000USD | -152,259,000USD | -169,618,000USD |
| Investments | -199,036,000USD | -30,538,000USD | 31,998,000USD | 73,241,000USD | -69,980,000USD | 200,096,000USD | -164,707,000USD | -69,385,000USD |
| Total Cashflows From Investing Activities | -302,564,000USD | -30,538,000USD | 31,998,000USD | 73,241,000USD | -71,102,000USD | 192,509,000USD | -165,836,000USD | -71,489,000USD |
| Total Cash From Financing Activities | 49,883,000USD | 6,845,000USD | 25,129,000USD | 8,199,000USD | 18,162,000USD | 80,996,000USD | 371,847,000USD | 306,647,000USD |
| Issuance Of Capital Stock | 49,883,000USD | 6,845,000USD | 25,129,000USD | 8,199,000USD | 18,162,000USD | 80,996,000USD | 371,847,000USD | 306,647,000USD |
| Change In Cash | -141,894,000USD | 133,932,000USD | 73,811,000USD | -32,589,000USD | -178,593,000USD | 137,331,000USD | 54,883,000USD | 67,691,000USD |
| Begin Period Cash Flow | 319,589,000USD | 194,427,000USD | 114,846,000USD | 153,205,000USD | 331,798,000USD | 194,467,000USD | 139,584,000USD | 71,893,000USD |
| End Period Cash Flow | 177,695,000USD | 328,359,000USD | 188,657,000USD | 120,616,000USD | 153,205,000USD | 331,798,000USD | 194,467,000USD | 139,584,000USD |
| Unclassified Operating Cash Flow | -302,014,000USD | — | — | — | — | 2,748,000USD | — | — |
| Unclassified Investing Cash Flow | -98,838,000USD | -145,992,000USD | 8,002,000USD | -73,241,000USD | 69,980,000USD | -200,096,000USD | 164,707,000USD | — |
| Other Cashflows From Investing Activities | — | 146,515,000USD | 32,048,000USD | 73,241,000USD | -69,980,000USD | 200,096,000USD | -164,707,000USD | 44,000USD |
| Other Cashflows From Financing Activities | — | — | 31,998,000USD | 73,241,000USD | -71,102,000USD | 192,509,000USD | 371,847,000USD | 306,647,000USD |
| Unclassified Financing Cash Flow | — | — | -31,998,000USD | -73,241,000USD | 71,102,000USD | -192,509,000USD | -371,847,000USD | -306,647,000USD |
| Change To Liabilities | — | — | — | 5,870,000USD | -8,218,000USD | 31,159,000USD | 12,010,000USD | 11,742,000USD |
| Sale Purchase Of Stock | — | — | — | — | 18,162,000USD | 80,996,000USD | 371,847,000USD | 306,647,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | -178,600,000USD | 137,339,000USD | 54,881,000USD | 67,688,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2016Yearly · 2016-12-31 | Product | Product | 17,327,000 | USD | 0001564590-19-004596 |
| FY 2016Yearly · 2016-12-31 | Product | Product And Service Other | 4,000 | USD | 0001564590-19-004596 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.